Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) — Financial Flexibility Index
Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥118.65 Million (operating CF CN¥79.81 Million minus capex CN¥38.83 Million) represents 0% of total liabilities (CN¥1.42 Billion). Check 300233 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Shandong Jincheng Pharmaceutical and Chemical Co Ltd across 18 annual periods. See Shandong Jincheng Pharmaceutical and Che short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Shandong Jincheng Pharmaceutical and Chemical Co Ltd. For the full company profile including market capitalisation, see 300233 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | CN¥420.52 Million | CN¥319.64 Million | CN¥1.47 Billion | ▲ +15.7% |
| 2024 | 0.25x | CN¥439.20 Million | CN¥296.59 Million | CN¥1.77 Billion | ▼ -47.5% |
| 2023 | 0.47x | CN¥1.01 Billion | CN¥664.08 Million | CN¥2.14 Billion | ▲ +62.4% |
| 2022 | 0.29x | CN¥629.29 Million | CN¥255.63 Million | CN¥2.17 Billion | ▼ -34.4% |
| 2021 | 0.44x | CN¥813.33 Million | CN¥437.19 Million | CN¥1.84 Billion | ▼ -17.0% |
| 2020 | 0.53x | CN¥818.56 Million | CN¥546.13 Million | CN¥1.53 Billion | ▼ -14.3% |
| 2019 | 0.62x | CN¥939.63 Million | CN¥577.98 Million | CN¥1.51 Billion | ▲ +6.4% |
| 2018 | 0.59x | CN¥702.08 Million | CN¥352.20 Million | CN¥1.20 Billion | ▲ +63.8% |
| 2017 | 0.36x | CN¥345.63 Million | CN¥151.83 Million | CN¥966.24 Million | ▼ -32.8% |
| 2016 | 0.53x | CN¥400.38 Million | CN¥241.48 Million | CN¥752.68 Million | ▼ -0.8% |
| 2015 | 0.54x | CN¥367.77 Million | CN¥207.92 Million | CN¥685.95 Million | ▼ -5.4% |
| 2014 | 0.57x | CN¥379.02 Million | CN¥219.46 Million | CN¥668.61 Million | ▲ +23.6% |
| 2013 | 0.46x | CN¥254.10 Million | CN¥93.92 Million | CN¥554.11 Million | ▲ +15.7% |
| 2012 | 0.40x | CN¥195.81 Million | CN¥86.61 Million | CN¥494.26 Million | ▼ -12.0% |
| 2011 | 0.45x | CN¥197.69 Million | CN¥62.69 Million | CN¥439.36 Million | ▲ +7.7% |
| 2010 | 0.42x | CN¥243.46 Million | CN¥108.67 Million | CN¥582.62 Million | ▼ -13.3% |
| 2009 | 0.48x | CN¥198.21 Million | CN¥105.62 Million | CN¥411.04 Million | ▲ +137.7% |
| 2008 | 0.20x | CN¥83.10 Million | CN¥30.23 Million | CN¥409.67 Million | — |